META, ELDA
 Distribuzione geografica
Continente #
EU - Europa 774
Totale 774
Nazione #
IT - Italia 774
Totale 774
Città #
Genova 437
Rapallo 123
Genoa 114
Vado Ligure 99
Bordighera 1
Totale 774
Nome #
The pyrazolyl-urea GeGe3 inhibits tumor angiogenesis and reveals dystrophia myotonica protein Kinase (DMPK)1 as a novel angiogenesis target 126
Pyrazole and imidazo[1,2-b]pyrazole derivatives as new potential anti-tuberculosis agents. 120
Design, synthesis and biological evaluation of new pyrazolyl-ureas and imidazopyrazolecarboxamides able to interfere with MAPK and PI3K upstream signaling involved in the angiogenesis 107
3-Cyclopentyloxy-4-Methoxyphenyl-isoxazoline derivatives as new PDE4 inhibitors. 91
Development of imidazo-pyrazole derivatives as potential antimetastatic agents in neuroblastoma 74
The kinase inhibitor pyrazolyl-urea GeGe3 inhibits angiogenesis and reveals dystrophia myotonica protein kinase (DMPK)1 as a novel angiogenesis target 61
Biological evaluation of pyrazolyl-urea and dihydro-imidazopyrazolyl-urea derivatives as potential anti-angiogenetic agents in the treatment of neuroblastoma 57
The Kinase Inhibitor Pyrazolyl-Urea Gege3 Inhibits Angiogenesis And Reveals Dystrophia Myotonica Protein Kinase (DMPK)1 As A Novel Angiogenesis Target 48
New kinases targeted compounds as possible antiangiogenic and antimetastatic agents 45
New series of pyrazoles and imidazo‐pyrazoles targeting different cancer and inflammation pathways 42
Erratum: Correction: Biological evaluation of pyrazolyl-urea and dihydro-imidazo-pyrazolyl-urea derivatives as potential anti-angiogenetic agents in the treatment of neuroblastoma (Oncotarget) 22
null 17
Synthesis, functional proteomics and biological evaluation of new 5-pyrazolyl ureas as potential anti-angiogenic compounds 6
Totale 816
Categoria #
all - tutte 3.466
article - articoli 2.717
book - libri 0
conference - conferenze 749
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.932


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020125 0 0 0 0 0 0 30 13 18 33 26 5
2020/202158 1 4 4 8 0 9 3 10 6 8 4 1
2021/2022115 10 5 2 8 4 8 2 33 13 15 0 15
2022/2023149 11 17 2 22 20 18 0 13 14 0 27 5
2023/202489 4 14 2 15 19 9 5 2 2 4 2 11
2024/2025108 4 25 3 26 29 21 0 0 0 0 0 0
Totale 816